{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:10:19Z","timestamp":1780103419735,"version":"3.54.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T00:00:00Z","timestamp":1368144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12031-013-0022-8","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T01:45:06Z","timestamp":1368063906000},"page":"539-549","source":"Crossref","is-referenced-by-count":13,"title":["Edaravone Prevents Neurotoxicity of Mutant L166P DJ-1 in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"51","author":[{"given":"Bing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,10]]},"reference":[{"key":"22_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2005.04.036","volume":"516","author":"S Amemiya","year":"2005","unstructured":"Amemiya S, Kamiya T, Nito C, Inaba T, Kato K, Ueda M, Shimazaki K, Katayama Y (2005) Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats. Eur J Pharmacol 516:125\u2013130","journal-title":"Eur J Pharmacol"},{"key":"22_CR2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, van Baren MJ et al (2003a) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256\u2013259","journal-title":"Science"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10072-003-0108-0","volume":"24","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, Brice A, van Duijn CM, Oostra B, Meco G et al (2003b) DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 24:159\u2013160","journal-title":"Neurol Sci"},{"key":"22_CR4","doi-asserted-by":"crossref","first-page":"9103","DOI":"10.1073\/pnas.0402959101","volume":"101","author":"RM Canet-Avil\u00e9s","year":"2004","unstructured":"Canet-Avil\u00e9s RM, Wilson MA, Miller DW, Ahmad R, McLendon C, Bandyopadhyay S, Baptista MJ, Ringe D, Petsko GA, Cookson MR (2004) The Parkinson\u2019s disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A 101:9103\u20139108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"22_CR5","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1111\/j.1471-4159.2008.05573.x","volume":"106","author":"H Chen","year":"2008","unstructured":"Chen H, Wang S, Ding JH, Hu G (2008) Edaravone protects against MPP+-induced cytotoxicity in rat primary cultured astrocytes via inhibition of mitochondrial apoptotic pathway. J Neurochem 106(6):2345\u20132352","journal-title":"J Neurochem"},{"issue":"9","key":"22_CR6","doi-asserted-by":"crossref","first-page":"a009415","DOI":"10.1101\/cshperspect.a009415","volume":"2","author":"MR Cookson","year":"2012","unstructured":"Cookson MR (2012) Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways. Cold Spring Harb Perspect Med 2(9):a009415","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"22_CR7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchemneu.2011.07.003","volume":"42","author":"D Crosiers","year":"2011","unstructured":"Crosiers D, Theuns J, Cras P, Van Broeckhoven C (2011) Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes. J Chem Neuroanat 42(2):131\u2013141","journal-title":"J Chem Neuroanat"},{"key":"22_CR8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1083\/jcb.200904103","volume":"188","author":"S Deeg","year":"2010","unstructured":"Deeg S, Gralle M, Sroka K, Bahr M, Wouters FS, Kermer P (2010a) BAG1 restores formation of functional DJ-1 L166P dimers and DJ-1 chaperone activity. J Cell Biol 188:505\u2013513","journal-title":"J Cell Biol"},{"key":"22_CR9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1083\/jcb.200904103","volume":"188","author":"S Deeg","year":"2010","unstructured":"Deeg S, Gralle M, Sroka K, Bahr M, Wouters FS, Kermer P (2010b) BAG1 restores formation of functional DJ-1 L166P dimers and DJ-1 chaperone activity. J Cell Biol 188:505\u2013513","journal-title":"J Cell Biol"},{"key":"22_CR10","doi-asserted-by":"crossref","unstructured":"Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med [Epub ahead of print]","DOI":"10.1016\/j.freeradbiomed.2013.01.018"},{"key":"22_CR11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000069318","volume":"15","author":"Edaravone Acute Infarction Study G","year":"2003","unstructured":"Edaravone Acute Infarction Study G (2003) Effect of a novel free radical scavenger, edaravone (mci-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 15:222\u2013229","journal-title":"Cerebrovasc Dis"},{"key":"22_CR12","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1074\/jbc.M707176200","volume":"283","author":"J Fan","year":"2008","unstructured":"Fan J, Ren H, Jia N, Fei E, Zhou T, Jiang P, Wu M, Wang G (2008) DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J Biol Chem 283:4022\u20134030","journal-title":"J Biol Chem"},{"key":"22_CR13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/cdd.2009.116","volume":"17","author":"E Giaime","year":"2010","unstructured":"Giaime E, Sunyach C, Druon C et al (2010) Loss of function of DJ-1 triggered by Parkinson\u2019s disease-associated mutation is due to proteolytic resistance to caspase-6. Cell Death Differ 17:158\u2013169","journal-title":"Cell Death Differ"},{"key":"22_CR14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/hmg\/ddi445","volume":"15","author":"CE Glatt","year":"2006","unstructured":"Glatt CE, Wahner AD, White DJ, Ruiz-Linares A, Ritz B (2006) Gain-offunction haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women. Hum Mol Genet 15:299\u2013305","journal-title":"Hum Mol Genet"},{"key":"22_CR15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","volume":"45","author":"MS Goldberg","year":"2005","unstructured":"Goldberg MS, Pisani A, Haburcak M et al (2005) Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45:489\u2013496","journal-title":"Neuron"},{"key":"22_CR16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.expneurol.2008.07.017","volume":"213","author":"H Ito","year":"2008","unstructured":"Ito H, Wate R, Zhang J, Ohnishi S, Kaneko S et al (2008) Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice. Exp Neurol 213:448\u2013455","journal-title":"Exp Neurol"},{"key":"22_CR17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12640-009-9081-6","volume":"16","author":"T Itoh","year":"2009","unstructured":"Itoh T, Satou T, Nishida S, Tsubaki M, Hashimoto S et al (2009) The novel free radical scavenger, edaravone, increases neural stem cell number around the area of damage following rat traumatic brain injury. Neurotox Res 16:378\u2013389","journal-title":"Neurotox Res"},{"issue":"2","key":"22_CR18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-3565(24)36676-5","volume":"281","author":"H Kawai","year":"1997","unstructured":"Kawai H, Nakai H, Suga M, Yuki S, Watanabe T, Saito KI (1997) Effects of a novel free radical scavenger, MCI-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther 281(2):921\u2013927","journal-title":"J Pharmacol Exp Ther"},{"key":"22_CR19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2006.05.012","volume":"542","author":"T Kawasaki","year":"2006","unstructured":"Kawasaki T, Ishihara K, Ago Y, Nakamura S, Itoh S, Baba A, Matsuda T (2006) Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum. Eur J Pharmacol 542:92\u201399","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"22_CR20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.106.119206","volume":"322","author":"T Kawasaki","year":"2007","unstructured":"Kawasaki T, Ishihara K, Ago Y, Baba A, Matsuda T (2007) Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum. J Pharmacol Exp Ther 322(1):274\u2013281","journal-title":"J Pharmacol Exp Ther"},{"key":"22_CR21","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","volume":"102","author":"RH Kim","year":"2005","unstructured":"Kim RH, Smith PD, Aleyasin H et al (2005) Hypersensitivity of DJ-1-deficient mice to 1-mthyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and oxidative stress. Proc Natl Acad Aci U S A 102:5215\u20135220","journal-title":"Proc Natl Acad Aci U S A"},{"key":"22_CR22","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","volume":"339","author":"AE Lang","year":"1998","unstructured":"Lang AE, Lozano AM (1998) Parkinson's disease. First of two parts. N Engl J Med 339:1044\u20131053","journal-title":"N Engl J Med"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson's disease. Lancet 373:2055\u20132066","journal-title":"Lancet"},{"key":"22_CR24","doi-asserted-by":"crossref","unstructured":"Lin Z, Zhao Y, Chung CY, Zhou Y, Xiong N, et al. (2010) High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life. FASEB J 24:2191\u20132200","DOI":"10.1096\/fj.09-140368"},{"key":"22_CR25","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.cub.2005.07.064","volume":"15","author":"M Meulener","year":"2005","unstructured":"Meulener M, Whitworth AJ, Armstrong-Gold CE, Rizzu P, Heutink P, Wes PD, Pallanck LJ, Bonini NM (2005) Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson\u2019s disease. Curr Biol 15:1572\u20131577","journal-title":"Curr Biol"},{"key":"22_CR26","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/cdd.2008.26","volume":"15","author":"JS Mo","year":"2008","unstructured":"Mo JS, Kim MY, Ann EJ, Hong JA, Park HS (2008) DJ-1 modulates UV-induced oxidative stress signaling through the suppression of MEKK1 and cell death. Cell Death Differ 15:1030\u20131041","journal-title":"Cell Death Differ"},{"key":"22_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","volume":"28","author":"DJ Moore","year":"2005","unstructured":"Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson\u2019s disease. Annu Rev Neurosci 28:57\u201387","journal-title":"Annu Rev Neurosci"},{"key":"22_CR28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/STROKEAHA.107.486654","volume":"39","author":"T Nakamura","year":"2008","unstructured":"Nakamura T, Kuroda Y, Yamashita S, Zhang X, Miyamoto O et al (2008) Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke 39:463\u2013469","journal-title":"Stroke"},{"key":"22_CR29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.109.070094","volume":"51","author":"N Okamura","year":"2010","unstructured":"Okamura N, Villemagne VL, Drago J, Pejoska S, Dhamija RK et al (2010) In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133. J Nucl Med 51:223\u2013228","journal-title":"J Nucl Med"},{"key":"22_CR30","doi-asserted-by":"crossref","first-page":"H2171","DOI":"10.1152\/ajpheart.00143.2003","volume":"285","author":"KG Rajesh","year":"2003","unstructured":"Rajesh KG, Sasaguri S, Suzuki R, Maeda H (2003) Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression. Am J Physiol Heart Circ Physiol 285:H2171\u2013H2178","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"22_CR31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1326-7-40","volume":"7","author":"H Ren","year":"2012","unstructured":"Ren H, Fu K, Mu C, Zhen X, Wang G (2012) L166P mutant DJ-1 promotes cell death by dissociating Bax from mitochondrial Bcl-XL. Mol Neurodegener 7:40","journal-title":"Mol Neurodegener"},{"key":"22_CR32","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1038\/sj.onc.1207523","volume":"23","author":"X Saelens","year":"2004","unstructured":"Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P (2004) Vandenabeele toxic proteins released from mitochondria in cell death. Oncogene 23:2861\u20132874","journal-title":"Oncogene"},{"issue":"2","key":"22_CR33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/0972-2327.82794","volume":"14","author":"P Sharma","year":"2011","unstructured":"Sharma P, Sinha M, Shukla R, Garg RK, Verma R, Singh MK (2011) A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke. Ann Indian Acad Neurol 14(2):103\u2013106","journal-title":"Ann Indian Acad Neurol"},{"issue":"10","key":"22_CR34","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.freeradbiomed.2009.02.018","volume":"46","author":"B Sheng","year":"2009","unstructured":"Sheng B, Gong K, Niu Y, Liu L, Yan Y, Lu G, Zhang L, Hu M, Zhao N, Zhang X, Tang P, Gong Y (2009) Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: implications for the treatment of Alzheimer's disease. Free Radic Biol Med 46(10):1362\u20131375","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"22_CR35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1471-4159.2011.07581.x","volume":"120","author":"B Sheng","year":"2012","unstructured":"Sheng B, Wang X, Su B, Lee HG, Casadesus G, Perry G, Zhu X (2012) Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J Neurochem 120(3):419\u2013429","journal-title":"J Neurochem"},{"key":"22_CR36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.embor.7400074","volume":"5","author":"T Taira","year":"2004","unstructured":"Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5:213\u2013218","journal-title":"EMBO Rep"},{"key":"22_CR37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjcard.2004.05.007","volume":"94","author":"K Tsujita","year":"2004","unstructured":"Tsujita K, Shimomura H, Kawano H, Hokamaki J, Fukuda M, Yamashita T, Hida S, Nakamura Y, Nagayoshi Y, Sakamoto T, Yoshimura M, Arai H, Ogawa H (2004) Effects of edaravone on reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 94:481\u2013484","journal-title":"Am J Cardiol"},{"key":"22_CR38","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1253\/circj.70.832","volume":"70","author":"K Tsujita","year":"2006","unstructured":"Tsujita K, Shimomura H, Kaikita K, Kawano H, Hokamaki J, Nagayoshi Y, Yamashita T, Fukuda M, Nakamura Y, Sakamoto T, Yoshimura M, Ogawa H (2006) Long-term efficacy of edaravone in patients with acute myocardial infarction. Circ J 70:832\u2013837","journal-title":"Circ J"},{"key":"22_CR39","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.051633998","volume":"98","author":"M Vila","year":"2001","unstructured":"Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S (2001) Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 98:2837\u20132842","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"22_CR40","doi-asserted-by":"crossref","first-page":"e20677","DOI":"10.1371\/journal.pone.0020677","volume":"6","author":"N Xiong","year":"2011","unstructured":"Xiong N, Xiong J, Khare G, Chen C, Huang J, Zhao Y, Zhang Z, Qiao X, Feng Y, Reesaul H, Zhang Y, Sun S, Lin Z, Wang T (2011a) Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease. PLoS One 6(6):e20677","journal-title":"PLoS One"},{"issue":"6","key":"22_CR41","doi-asserted-by":"crossref","first-page":"e20677","DOI":"10.1371\/journal.pone.0020677","volume":"6","author":"N Xiong","year":"2011","unstructured":"Xiong N, Xiong J, Khare G, Chen C, Huang J, Zhao Y, Zhang Z, Qiao X, Feng Y, Reesaul H, Zhang Y, Sun S, Lin Z, Wang T (2011b) Edaravone guards dopamine neurons in a rotenone model for Parkinson\u2019s disease. PLoS One 6(6):e20677","journal-title":"PLoS One"},{"issue":"2","key":"22_CR42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neulet.2012.10.043","volume":"531","author":"Y Yan","year":"2012","unstructured":"Yan Y, Gong K, Ma T, Zhang L, Zhao N, Zhang X, Tang P, Gong Y (2012) Protective effect of edaravone against Alzheimer's disease-relevant insults in neuroblastoma N2a cells. Neurosci Lett 531(2):160\u2013165","journal-title":"Neurosci Lett"},{"key":"22_CR43","doi-asserted-by":"crossref","unstructured":"Ying HS, Gottron FJ, Choi DW (2001) Assessment of cell viability in primary neuronal cultures. Curr Protoc Neurosci Chapter 7:Unit 7.18. doi: 10.1002\/0471142301.ns0718s13","DOI":"10.1002\/0471142301.ns0718s13"},{"key":"22_CR44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2202-9-75","volume":"9","author":"WJ Yuan","year":"2008","unstructured":"Yuan WJ, Yasuhara T, Shingo T, Muraoka K, Agari T et al (2008a) Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons. BMC Neurosci 9:75","journal-title":"BMC Neurosci"},{"key":"22_CR45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2202-9-75","volume":"9","author":"WJ Yuan","year":"2008","unstructured":"Yuan WJ, Yasuhara T, Shingo T et al (2008b) Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons. BMC Neurosci 9:75","journal-title":"BMC Neurosci"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-013-0022-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-013-0022-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-013-0022-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T09:17:56Z","timestamp":1746004676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-013-0022-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,10]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s12031-013-0022-8","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,10]]}}}